$603,250,000 in Total Settlement Funds Available. See if you qualify!Find Out More

Nabriva Therapeutics PLC Settlement
(NASDAQ: NBRV)
Settlement

Claim Deadline: April 30, 2021

Settlement Fund: $3,000,000

Settlement Class

All persons or entities that PURCHASED OR OTHERWISE ACQUIRED NABRIVA THERAPEUTICS PLC’S (“NABRIVA”) COMMON STOCK DURING THE PERIOD FROM JANUARY 4, 2019, THROUGH APRIL 30, 2019, BOTH DATES INCLUSIVE.

Important Documents

Settlement Status

Disbursed

Class Period

January 04, 2019 - April 30, 2019

Settlement Hearing Date

May 14, 2021

Opt-Out Deadline

April 30, 2021

Settlement Website

N/A

Claims Admin

A.B. Data, Ltd.
Nabriva Securities Litigation
Settlement Administrator
c/o A.B. Data, Ltd. P.O. Box 173091
Milwaukee, WI 53217
+1 800-918-9014
info@NabrivaSecuritiesLitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.